Naive CD8 + T cell activation results in an autonomous program of cellular proliferation and 2 9
binding. To determine whether enrichment of TF motifs at H3K27me3 demethylated sites 2 7 1 corresponded to specific TF binding, regions that exhibited loss or gain of H3K27me3 were 2 7 2 overlaid with publicly available T cell TF ChIP-seq data (Fig. 4D, E) . Supporting the TF 2 7 3 motif enrichment analysis (Fig. 4C) , stably demethylated regions in recently activated CD8 + 2 7 4
T cells were enriched for AP-1 (JUND-14.6%, BATF-15.2%, FOSL2-11.6%) and STAT 2 7 5
(STAT1-13.3%, STAT3-10.2%, STAT5A-11.8%) members, and TBX21 (12.1%) and IRF4 2 7 6 (15.4%) binding compared to either the transiently or delayed groups which ranged between 2 7 7 15 2 and 6% in the same dataset ( Fig. 4D, E) . In contrast, 19.3% of the transiently H3K27 2 7 8 demethylated regions and 17-20% of the regions exhibiting H3K27me3 gain overlapped with 2 7 9 SUZ12 binding, a component of the PRC2 complex that is responsible for H3K27me3 2 8 0 deposition (Fig. 4D, E) . This suggests that the observed upregulation of PRC2 components, 2 8 1 EZH2 and SUZ12, early after T cell activation may correlate with remethylation of 2 8 2 transiently demethylated regions soon after T cell activation. Importantly, a greater percentage of stably demethylated regions (21.8%) also showed 2 8 4 binding for the histone acetyltransferase, p300 compared to the transient demethylated 2 8 5 regions (8.8%, Fig. 4D, E) . The potential for p300 binding at these stably demethylated 2 8 6
regions was linked to genes that were transcriptionally induced in effector and/or memory T 2 8 7 cells (Supplementary Figure S4) . These data suggest that p300 binding and subsequent 2 8 8 acetylation of H3K27 is required for the demethylation to remain stable instead of transient. To test this, we overlaid our previous H3K27ac data from naïve, effector and memory CD8 + regions. In comparison to the transiently demethylated regions, there was a greater proportion 2 9 2 of the stably demethylated regions that either overlapped (10%) or were within 2kb (25%) or 2 9 3 5kb (38%) of a region with increased H3K27ac in effector T cells (Fig. 4F) . This trend was 2 9 4 similarly observed in memory T cells albeit at lower percentages (Fig. 4F) . These and memory T cells were positioned near differentially expressed genes linked to H3K27Ac + 2 9 7 regions (Supplementary Figure S4 ). Together these data support the notion that early H3K27me3 demethylation enables increased chromatin accessibility and this is further stabilised by the binding of p300 and subsequent H3K27 acetylation. Hence, within the first To test whether early H3K27me3 demethylation was necessary for induction of 3 0 6 appropriate virus-specific T cell differentiation, we treated naive OT-I CD8 + T cells with 3 0 7
GSK-J4, a small molecule inhibitor, which binds to the catalytic pocket of KDM6B Kruidenier et al., 2012) . This was followed by activation with the N4 peptide for 0, 1, 3, 5 3 0 9
and 24 hours ( Fig. 5A) . GSK-J4 inhibition of KDM6B activity prevented the removal of
H3K27me3 across all of the stimulation time points at the Tbx21, Irf4 and Irf8 promoters, (GSK-J5) ( Fig. 5B) .
1 5
Given the capacity of GSK-J4 to inhibit early H3K27 demethylation after CD8 + T cell 3 1 6 activation, we next determined whether GSK-J4 treatment of naive OT-I CD8 + T cells would 3 1 7
impact virus-specific CD8 + T cell differentiation. Naive, CellTrace Violet (CTV) labelled 3 1 8
OT-I T cells were treated with the GSK-J4 inhibitor, or GSK-J5 analogue for 4hrs in vitro.
An equal number of treated OT-I T cells were then adoptively transferred into recipient B6 3 2 0 mice infected 3 days prior to transfer with the A/HKx31-OVA virus (Fig. 5C ). Pre-treating 3 2 1
OT-I T cells with either the J5 control or the GSK-J4 inhibitor did not affect the viability of cells had undergone fewer divisions (Fig. 5F ). This result complimented our earlier 3 2 8 bioinformatic analysis that indicated that H3K27me3 demethylation was required to engage 3 2 9
gene networks involved in cell division and cell cycling ( Fig. 3D) . Therefore, the inability to that early H3K27 methylation was also required for acquisition of lineage-specific functions. Braciale, 2004). Hence, H3K27 demethylation, prior to initial cell division, appears to be a H3K27me3 removal is required for establishing virus-specific CD8 + T cell memory
It has previously been demonstrated that diminished effector responses can still lead to 3 5 1 effective CD8+ T cell memory populations (Badovinac et al., 2004; Zehn et al., 2009) . We 3 5 2 therefore next examined whether CD8+ T cell memory T cell formation was left intact after 3 5 3 inhibition of KDM6B-dependent H3K27me3 demethylation prior to initial activation. Naive OT-I CD8 + T cells treated with either the GSK-J5 analogue, or the GSK-J4 drug, and were 3 5 5
adoptively transferred into B6 recipient mice that had been infected with A/HKx31-OVA one 3 5 6 day prior. The primary and secondary OT-I responses were then assessed at the peak of the 3 5 7
primary response (day 10), memory (day 30) or after secondary challenge with A/PR8-OVA 3 5 8
(day 6, secondary) ( Fig. 6A) . In support of our earlier data, GSK-J4 treatment had a profound 3 5 9
impact on the expansion of OT-I CD8 + T cells optimal during the primary acute effector significantly reduced frequency and number of total memory OT-I CD8 + T cells ( Fig. 6C ).
6 5
Utilising intravital injection of anti-CD3 antibody to distinguish resident versus circulating 3 6 6 memory CTL, we determined that GSK-J4 treatment also resulted in fewer tissue resident 3 6 7 CD69 + CD103 + memory OT-Is ( Fig. 6D) . Thus it appears that inhibition of H3K27me3
demethylation impacted the formation of effector and memory CTL populations. It has been previously demonstrated that limiting initial effector T cell expansion does IAV-OVA ( Fig. 6B, E) . Memory OT-I T cells established after transfer and primary 3 7 5
19 activation of GSK-J4-treated OT-Is failed to expand upon secondary infection. This was 3 7 6 evident in the spleen (Fig. 6B) , the bronchoalveolar lavage fluid (BAL) and mLN ( Fig. 6E ).
7 7
Together these data suggest that a failure to remove H3K27me3 early after activation not 3 7 8
only impacts initial T cell expansion, but also programming of memory recall potential. This was likely not due to a difference in starting memory T cell number as the fold expansion in indicates an intrinsic defect in recall capacity.
3 8 2
To further consolidate our finding that KDM6B plays a role in programming optimal CD8 + T to first cell division negatively impacts subsequent optimal differentiation of virus-specific 4 1 5
CTL and establishment of virus-specific CD8 + T cell memory.
1 6
It is now well accepted that genome wide changes in chromatin accessibility and post- deposition is evident during thymic T cell development (Zhang et al., 2012) . In this study, transcription prior to cell division. T-BET upregulation was prior to the emergence of TBX21 as BATF/IRF4/RUNX3, by targeting CD8 + T cell specific gene loci to further modulate 4 7 8 chromatin remodelling. These results are reminiscent of a mechanism observed in stem cell cytokines. These data further support the idea that molecular re-programming in the lymph 4 9 3 node during the early stages of T cell activation is a key step for optimal effector T cell 4 9 4 differentiation.
9 5
Deposition of H3K27me3 at key pro-memory genes has been reported to be important repressive histone mark, H3K9me3, was required for shutting down pro-memory gene loci 4 9 9
24 enabling optimal effector CD8+ T cell differentiation (Pace et al., 2018) . Further, limiting T 5 0 0 cell proliferation has also been observed to promote formation of memory CD8 + T cell 5 0 1
populations (Badovinac et al., 2005; Badovinac et al., 2004; Zehn et al., 2009) . This is 5 0 2 supported by the notion that effector CTL are more terminally differentiated compared to and memory CD8 + T cell fates. This data also suggests that commitment to effector and 5 1 0 memory T cell fates are independent processes. This might reflect the role of distinct TFs.
1 1
For example, we observed sequential unmasking of specific TF motifs for EOMES and 5 1 2 RUNX3 TFs that have been shown to alter CD8 + T cell differential potential for the the timely commitment to both effector and memory T cell fates. stimulation with the N4 peptide in the presence of rhIL-2 (10U/mL) for 3, 5 and 24 hours. shown as mean ± SEM from 3 independent repeats with statistical significance calculated 5 5 6
using a one-tailed Student's T-test (*p<0.05 **p<0.01, ***p<0.001). or on OT-I T cells simulated as described above in Figure 1 . Data was mapped back to the 5 7 0 mouse genome (version mm10). Genomic regions that either lost or gained H3K27me3 H3K27me3. The number of regions in the groups of "transient", "stable", "delayed" 5 7 4
H3K27me3 loss and gain were within either 1000, 5000 and 10,000 base pairs (bp) of the 5 7 5
transcription start site of differentially expressed genes identified after in vitro activation (see H3K27me3 was carried out and hierarchical clustering based on p value carried out. Total RNA was extracted using Trizol® from unstimulated or stimulated OT-I CD8 + T cells. For gene expression analysis, 100μg mRNA was converted to cDNA using the Omniscript kit ChIP-DNA was prepared for sequencing using the NEBNext® CHIP-seq Library Prep Science 298, 1039-1043. Histone Demethylase UTX. Immunity 43, 703-714. Immunol 13, 502-513. cells. Proc Natl Acad Sci U S A 108, 15306-15311. Gearing, L.J., Cumming, H.E., Chapman, R., Finkel, A.M., Woodhouse, I.B., Luu, K., Gould, transcription factor binding sites. PLoS One 14, e0215495. W.N. (2015) . Inducible RNAi in vivo reveals that the transcription factor BATF is required to 8 3 0
